These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 7561133)

  • 1. Detection of Haemophilus ducreyi lipooligosaccharide by means of an immunolimulus assay.
    Hansen EJ; Lumbley SR; Saxen H; Kern K; Cope LD; Radolf JD
    J Immunol Methods; 1995 Sep; 185(2):225-35. PubMed ID: 7561133
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Monoclonal antibodies reactive with all strains of Haemophilus ducreyi.
    Hansen EJ; Loftus TA
    Infect Immun; 1984 Apr; 44(1):196-8. PubMed ID: 6200440
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Monoclonal antibodies against Haemophilus lipopolysaccharides: clone DP8 specific for Haemophilus ducreyi and clone DH24 binding to lacto-N-neotetraose.
    Borrelli S; Roggen EL; Hendriksen D; Jonasson J; Ahmed HJ; Piot P; Jansson PE; Lindberg AA
    Infect Immun; 1995 Jul; 63(7):2665-73. PubMed ID: 7790083
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structurally defined epitopes of Haemophilus ducreyi lipooligosaccharides recognized by monoclonal antibodies.
    Ahmed HJ; Frisk A; Månsson JE; Schweda EK; Lagergård T
    Infect Immun; 1997 Aug; 65(8):3151-8. PubMed ID: 9234768
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Monoclonal antibodies against Haemophilus ducreyi lipooligosaccharide and their diagnostic usefulness.
    Ahmed HJ; Borrelli S; Jonasson J; Eriksson L; Hanson S; Höjer B; Sunkuntu M; Musaba E; Roggen EL; Lagergård T
    Eur J Clin Microbiol Infect Dis; 1995 Oct; 14(10):892-8. PubMed ID: 8605903
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antibodies specific to surface antigens are not effective in complement-mediated killing of Haemophilus ducreyi.
    Frisk A; Ahmed HJ; Van Dyck E; Lagergård T
    Microb Pathog; 1998 Aug; 25(2):67-75. PubMed ID: 9712686
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of Haemophilus ducreyi bacteria, cytotoxin, endotoxin and antibodies in animal models for study of chancroid.
    Lagergård T
    Microb Pathog; 1992 Sep; 13(3):203-17. PubMed ID: 1291843
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rapid detection of Haemophilus ducreyi in clinical and experimental infections using monoclonal antibody: a preliminary evaluation.
    Karim QN; Finn GY; Easmon CS; Dangor Y; Dance DA; Ngeow YF; Ballard RC
    Genitourin Med; 1989 Dec; 65(6):361-5. PubMed ID: 2693334
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Humoral immune response of humans to lipooligosaccharide and outer membrane proteins of Haemophilus ducreyi.
    Alfa MJ; Olson N; Degagne P; Plummer F; Namaara W; Maclean I; Ronald AR
    J Infect Dis; 1993 May; 167(5):1206-10. PubMed ID: 8486955
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antibodies directed against Haemophilus ducreyi heat shock proteins.
    Brown TJ; Jardine J; Ison CA
    Microb Pathog; 1993 Aug; 15(2):131-9. PubMed ID: 8255206
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of a rapid immunodiagnostic test for Haemophilus ducreyi.
    Patterson K; Olsen B; Thomas C; Norn D; Tam M; Elkins C
    J Clin Microbiol; 2002 Oct; 40(10):3694-702. PubMed ID: 12354868
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of an 18,000-molecular-weight outer membrane protein of Haemophilus ducreyi that contains a conserved surface-exposed epitope.
    Spinola SM; Griffiths GE; Bogdan J; Menegus MA
    Infect Immun; 1992 Feb; 60(2):385-91. PubMed ID: 1370430
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Production of monoclonal antibodies specific for Haemophilus ducreyi: a screening method to discriminate specific and cross-reacting antibodies.
    Odumeru JA; Alfa MJ; Martin CF; Ronald AR; Jay FT
    Hybridoma; 1989 Jun; 8(3):337-51. PubMed ID: 2787274
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inducible immunity with a pilus preparation booster vaccination in an animal model of Haemophilus ducreyi infection and disease.
    Desjardins M; Filion LG; Robertson S; Cameron DW
    Infect Immun; 1995 May; 63(5):2012-20. PubMed ID: 7729916
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of normal and immune sera on Haemophilus ducreyi 35000HP and its isogenic MOMP and LOS mutants.
    Hiltke TJ; Bauer ME; Klesney-Tait J; Hansen EJ; Munson RS; Spinola SM
    Microb Pathog; 1999 Feb; 26(2):93-102. PubMed ID: 10090856
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of enzyme immunoassays for antibodies to Haemophilus ducreyi in a community outbreak of chancroid in the United States.
    Chen CY; Mertz KJ; Spinola SM; Morse SA
    J Infect Dis; 1997 Jun; 175(6):1390-5. PubMed ID: 9180178
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Defining Potential Vaccine Targets of Haemophilus ducreyi Trimeric Autotransporter Adhesin DsrA.
    Fusco WG; Choudhary NR; Stewart SM; Alam SM; Sempowski GD; Elkins C; Leduc I
    Monoclon Antib Immunodiagn Immunother; 2015 Apr; 34(2):73-82. PubMed ID: 25897604
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neutralizing antibodies to Haemophilus ducreyi cytotoxin.
    Lagergård T; Purvén M
    Infect Immun; 1993 Apr; 61(4):1589-92. PubMed ID: 8454369
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of a transposon Tn916-generated mutant of Haemophilus ducreyi 35000 defective in lipooligosaccharide biosynthesis.
    Gibson BW; Campagnari AA; Melaugh W; Phillips NJ; Apicella MA; Grass S; Wang J; Palmer KL; Munson RS
    J Bacteriol; 1997 Aug; 179(16):5062-71. PubMed ID: 9260947
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cloning and characterization of the lipooligosaccharide galactosyltransferase II gene of Haemophilus ducreyi.
    Sun S; Schilling B; Tarantino L; Tullius MV; Gibson BW; Munson RS
    J Bacteriol; 2000 Apr; 182(8):2292-8. PubMed ID: 10735874
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.